A Review on Different Analytical Techniques for Determination of DNP Drugs and their Metabolites in Pharmaceutical Formulations

被引:1
作者
Bag, Puja [1 ]
Kumar, Bhupinder [1 ,2 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut Anal, GT Rd, Moga 142001, Punjab, India
[2] ISF Coll Pharm, Dept Pharmaceut Chem, GT Rd, Moga 142001, Punjab, India
关键词
Diabetic neuropathy drugs; liquid chromatography-mass spectrometry; high performance liquid chromatography; ultraviolet-visible spectrophotometer method; analytical method development; pharmaceutical analysis; DIABETIC PERIPHERAL NEUROPATHY; ALPHA-LIPOIC ACID; LC-MS/MS METHOD; HUMAN PLASMA; RAT PLASMA; PHARMACOLOGICAL-TREATMENT; PAINFUL NEUROPATHY; GLYCEMIC CONTROL; HPLC METHOD; PREGABALIN;
D O I
10.2174/1573412916999200825112708
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Neuropathy is the most common perplexity of diabetes type 1 and 2. About 50% of diabetic patients develop diabetic neuropathic pain (DNP). At the beginning of diabetic neuropathy, there is a loss of sense, especially in the lower limb, accompanied by pain, and difficulty in movement. Glucose regulation effectively prevents the development of diabetic neuropathy in type 1 diabetic patients, but the consequences in type 2 diabetic patients are more drastic. Introduction: No single treatment exists to prevent or renovate the pain caused by diabetic neuropathy. The drugs used for the treatment of DNP come in various formulations and with different storage conditions. To date, a number of analytical methodologies have been reported for the analysis of DNP drugs. Few reports are published describing analytical methods of single DNP drugs. Methods: The main objective of this review is to compile the different analytical methods developed at UV-Vis (Ultraviolet-visible) spectrophotometer, HPLC (High Performance Liquid Chromatography), and LC-MS (Liquid Chromatography-Mass spectrometry) to identify and quantify the drug content in various formulations, which are used to treat or prevent the diabetic neuropathic pain mainly focusing on gamma-aminobutyric acid analogues, anti-depressants, Serotonin Noradrenaline Reuptake Inhibitors (SNRIs), aldose reductase inhibitors, opioids, and dietary supplements. Results and Discussion: We have compiled UV-Vis, HPLC, and Liquid Chromatography-Mass spectrometry analytical methods developed to study the pharmacokinetic profile, quantify drug content, and their metabolites in plasma as well as pharmaceutical formulations. Conclusion: The authors believe that the mentioned studies in the report will help audible readers to select a suitable method for analysis of these drugs and also help researchers to develop a more convenient, fast, and sensitive method for these.
引用
收藏
页码:1132 / 1155
页数:24
相关论文
共 102 条
  • [11] Bhatt Nejal M, 2015, J Pharm Anal, V5, P1, DOI 10.1016/j.jpha.2014.08.001
  • [12] Bindaiya Shailendra, 2012, IJPC, V2, P85
  • [13] Boulton AJ., 2005, Clin Diabetes, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9
  • [14] Diabetic neuropathies - A statement by the American Diabetes Association
    Boulton, AJM
    Vinik, AI
    Arezzo, JC
    Bril, V
    Feldman, EL
    Freeman, R
    Malik, RA
    Maser, RE
    Sosenko, JM
    Ziegler, D
    [J]. DIABETES CARE, 2005, 28 (04) : 956 - 962
  • [15] Diabetic somatic neuropathies
    Boulton, AJM
    Malik, RA
    Arezzo, JC
    Sosenko, JM
    [J]. DIABETES CARE, 2004, 27 (06) : 1458 - 1486
  • [16] Practical liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of amitriptyline, nortriptyline and their hydroxy metabolites in human serum
    Buhagiar, Luana Mifsud
    Sammut, Carmel
    Chircop, Yana
    Axisa, Kersty
    Bartolo, Nicolette Sammut
    Sziji, Janis Vella
    Inglott, Anthony Serracino
    LaFerla, Godfrey
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2019, 33 (12)
  • [17] Painful Diabetic Neuropathy: Many Similarly Effective Therapies With Widely Dissimilar Costs
    Callaghan, Brian C.
    Feldman, Eva L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (09) : 674 - U96
  • [18] Diabetic neuropathy: clinical manifestations and current treatments
    Callaghan, Brian C.
    Cheng, Hsinlin T.
    Stables, Catherine L.
    Smith, Andrea L.
    Feldman, Eva L.
    [J]. LANCET NEUROLOGY, 2012, 11 (06) : 521 - 534
  • [19] Mechanisms of distal axonal degeneration in peripheral neuropathies
    Cashman, Christopher R.
    Hoeke, Ahmet
    [J]. NEUROSCIENCE LETTERS, 2015, 596 : 33 - 50
  • [20] Quantitative determination of duloxetine and its metabolite in rat plasma by HPLC-MS/MS
    Chae, Jung-woo
    Baek, Hyun-moon
    Kim, Sang Kyum
    Kang, Ho-il
    Kwon, Kwang-il
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (08) : 953 - 955